Retour


16/11/2017
Kurma Partners announces the successful IPO of Orphazyme.
Kurma Partners announces the successful IPO of Orphazyme, a leading company in rare diseases which raises €80M on Nasdaq Copenhagen [....]

Télécharger le fichier pdf





X

X